Abstract: Extracorporeal cell-based therapeutic devices and delivery systems are disclosed which provide a method for therapeutic delivery of biologically active molecules produced by living cells in response to a dynamic physiologic environment. Exemplary designs are disclosed. In a first exemplary embodiment the device includes long hollow fibers in which a layer of cells are grown within the intraluminal volume or within a double hollow-filled chamber. In another exemplary embodiment the device includes a wafer or a series of wafers forms a substrate onto which cells are grown. The wafer(s) are then inserted into a device. The devices are intended to be extracorporeal. Disclosed is a device for delivering a pre-selected molecule, for example, a hormone, into a mammal's systemic circulation. The device may also deliver a member of different cell products. The device comprises an anchoring element that can be anchored to an inner wall of an extracorporeal tube for blood.
Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
Type:
Application
Filed:
April 15, 2011
Publication date:
August 11, 2011
Applicants:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN, INNOVATIVE BIOTHERAPIES, INC.
Abstract: Extracorporeal cell-based therapeutic devices and delivery systems are disclosed which provide a method for therapeutic delivery of biologically active molecules produced by living cells in response to a dynamic physiologic environment. One embodiment includes long hollow fibers in which a layer of cells are grown within the intraluminal volume or within a double hollow-filled chamber. Another embodiment includes a wafer or a series of wafers providing a substrate onto which cells are grown. The wafer(s) are inserted into a device. A device may deliver a pre-selected molecule, for example, a hormone, into a mammal's systemic circulation and/or may deliver a member of different cell products. The device is adapted to secure viable cells which produce and secrete the pre-selected molecule into blood or fluid. The invention also provides a minimally invasive method for percutaneously introducing into a preselected blood vessel or body cavity the device of the invention.
Type:
Application
Filed:
February 15, 2011
Publication date:
August 4, 2011
Applicant:
Innovative BioTherapies, Inc.
Inventors:
H. David Humes, Deborah Buffington, Gretchen Hageman
Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
Type:
Application
Filed:
June 30, 2010
Publication date:
October 21, 2010
Applicants:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN, INNOVATIVE BIOTHERAPIES, INC.
Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
Type:
Application
Filed:
June 30, 2010
Publication date:
October 21, 2010
Applicants:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN, INNOVATIVE BIOTHERAPIES, INC.
Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
Type:
Application
Filed:
June 30, 2010
Publication date:
October 21, 2010
Applicants:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN, INNOVATIVE BIOTHERAPIES, INC.
Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
Type:
Application
Filed:
June 30, 2010
Publication date:
October 21, 2010
Applicants:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN, INNOVATIVE BIOTHERAPIES, INC.